Skip to content
Recall Observatory FDA recall evidence

Drug product

Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99

D-1232-2020

March 18, 2020

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 85183
Status
Terminated
Classification
Class II
Quantity
26625 units
Official record key
drug-enforcement:D-1232-2020

Official wording

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Code information: Lot #: 198180048A, Exp. Date 04/2021; 198180061A, Exp. Date 06/2020; 19819017A1, Exp. Date 02/2021

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations